7th Annual Complement-Based Drug Development Summit

Presentation "The Life-Saving Anti-Inflammatory Potential of Blocking the C5a / C5aR Signaling Pathway”

Speaker: Prof. Dr. Niels Riedemann, Founder and CEO of InflaRx

Date: September 12th

Time: 5:10 pm EDT
 

Panel “What are the Future Applications of Complement Therapeutics; What Will the Landscape Look Like in 5 Years’ Time?

Date: September 13th

Time: 4:30 pm EDT

read more...